Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents

Cancer Chemotherapy and Pharmacology

Volumn 46, Issue 6, 2000, Pages 517-522

  Bonifati, Domenico Marco ^a   Ori, Carlo ^a   Rossi, Carlo Riccardo ^a   Caira, Stefania ^a   Fanin, Marina ^a   Angelini, Corrado ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Desmin; Doxorubicin; Hyperthermic limb perfusion; Melphalan; Muscle

Indexed keywords

ANTINEOPLASTIC AGENT; DESMIN; DOXORUBICIN; MELPHALAN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEG; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE INJURY; MUSCLE MITOCHONDRION; NERVE LESION; NEUROPATHY; PRIORITY JOURNAL; SARCOMA; TEMPERATURE; TISSUE LEVEL;

EID: 0033653661     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800000175     Document Type: Article

References (28)

1. Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients
2. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system
3. Ueber den Einfluss, welchen heftigere Erysipeln zuweilen auf organisierte Neubildungen ausuebten
4. The application of hyperthermia in regional chemotherapy
5. Prognostic variables in recurrent limb melanoma treated with hyperthermic antiblastic perfusion
6. Neurotoxicity of isolated limb perfusion with tumor necrosis factor
7. Definition of pathological changes seen in muscle biopsies
8. Desmin-related myopathies
9. Effect of sequential application of hyperthermia and chemotherapy on the survival of a thermoresistant human melanoma cell line
10. Thermochemotherapy: Synergism between hyperthermia (42-43 °C) and adriamycin (or beomycin) in mammalian cell inactivation
11. Molecular mechanisms of doxorubicin-induced cardiomyopathy
12. Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities
13. Regional chemotherapy for melanoma. A 35-year experience
14. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD
15. The value of monitoring serum creatine phosphokinase following hyperthermic isolated limb perfusion for melanoma
16. Immunologicical characterization of the subunit of the 100 A filaments from muscle cells
17. Anthracycline effects on actin and actin-containing thin filaments in cultured neonatal rat myocardial cells
18. Verapamil substantially increases the chemomyectomy effect of doxorubicin injected into rabbit or monkey eyelids
19. Doxorubicin chemomyectomy as a treatment for cervical dystonia: Histological assessment after direct injection into the sternocleidomastoid muscle
20. Acute morphological changes in orbicularis oculi muscle after doxorubicin injection into the eyelid
21. Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas
22. Prevention of neural and muscular lesions during hyperthermic regional perfusion
23. Hyperthermic isolated limb perfusion for the treatment of soft tissue sarcomas
24. Studies on the function and composition of the 10 nm filaments of vertebrate smooth muscle
25. Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs
26. Thirty-five years of isolated limb perfusion for melanoma: Indications and results
27. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reaction
28. Long term efficacy of local doxorubicin chemomyectomy in blepharospasm and hemifacial spasm patients